GRNOPC1
CP35A007
Phase 1 mab completed
Quick answer
GRNOPC1 for Spinal Cord Injury is a Phase 1 program (mab) at Lineage Cell Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lineage Cell Therapeutics
- Indication
- Spinal Cord Injury
- Phase
- Phase 1
- Modality
- mab
- Status
- completed